BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 36973407)

  • 1. Nucleotide metabolism: a pan-cancer metabolic dependency.
    Mullen NJ; Singh PK
    Nat Rev Cancer; 2023 May; 23(5):275-294. PubMed ID: 36973407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging roles of nucleotide metabolism in cancer.
    Shi DD; Savani MR; Abdullah KG; McBrayer SK
    Trends Cancer; 2023 Aug; 9(8):624-635. PubMed ID: 37173188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rethinking our approach to cancer metabolism to deliver patient benefit.
    Tardito S; MacKay C
    Br J Cancer; 2023 Aug; 129(3):406-415. PubMed ID: 37340094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of de novo nucleotide biosynthetic pathway enzymes in cancer and targeting opportunities.
    Robinson AD; Eich ML; Varambally S
    Cancer Lett; 2020 Feb; 470():134-140. PubMed ID: 31733288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted cancer therapeutics: biosynthetic and energetic pathways characterized by metabolomics and the interplay with key cancer regulatory factors.
    Dang NH; Singla AK; Mackay EM; Jirik FR; Weljie AM
    Curr Pharm Des; 2014; 20(15):2637-47. PubMed ID: 23859615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The oncogenic and clinical implications of lactate induced immunosuppression in the tumour microenvironment.
    Hayes C; Donohoe CL; Davern M; Donlon NE
    Cancer Lett; 2021 Mar; 500():75-86. PubMed ID: 33347908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Energy management - a critical role in cancer induction?
    Garland J
    Crit Rev Oncol Hematol; 2013 Oct; 88(1):198-217. PubMed ID: 23731619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in cancer metabolism: a technological perspective.
    Kang YP; Ward NP; DeNicola GM
    Exp Mol Med; 2018 Apr; 50(4):1-16. PubMed ID: 29657324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Connections between metabolism and epigenetics in cancers.
    Thakur C; Chen F
    Semin Cancer Biol; 2019 Aug; 57():52-58. PubMed ID: 31185282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting mTOR and Metabolism in Cancer: Lessons and Innovations.
    Magaway C; Kim E; Jacinto E
    Cells; 2019 Dec; 8(12):. PubMed ID: 31817676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the role of AMP-activated protein kinase in metabolic reprogramming of metastatic cancer cells: targeting cellular bioenergetics and biosynthetic pathways for anti-tumor treatment.
    Tyszka-Czochara M; Konieczny P; Majka M
    J Physiol Pharmacol; 2018 Jun; 69(3):. PubMed ID: 30279304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging roles of nucleotide metabolism in cancer development: progress and prospect.
    Ma J; Zhong M; Xiong Y; Gao Z; Wu Z; Liu Y; Hong X
    Aging (Albany NY); 2021 May; 13(9):13349-13358. PubMed ID: 33952722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic Metabolism Acts as a Prerequisite Step for Induction of Cancer Metastasis and Cancer Stem Cell Phenotype.
    Lee SY; Ju MK; Jeon HM; Lee YJ; Kim CH; Park HG; Han SI; Kang HS
    Oxid Med Cell Longev; 2018; 2018():1027453. PubMed ID: 30671168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer Metabolism: Phenotype, Signaling and Therapeutic Targets.
    Park JH; Pyun WY; Park HW
    Cells; 2020 Oct; 9(10):. PubMed ID: 33081387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A non-proliferative role of pyrimidine metabolism in cancer.
    Siddiqui A; Ceppi P
    Mol Metab; 2020 May; 35():100962. PubMed ID: 32244187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic signaling pathways associated with immune evasion and resistance to immune checkpoint inhibitors in cancer.
    Kobayashi Y; Lim SO; Yamaguchi H
    Semin Cancer Biol; 2020 Oct; 65():51-64. PubMed ID: 31874279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
    Amoedo ND; Obre E; Rossignol R
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer stem cell metabolism: a potential target for cancer therapy.
    Deshmukh A; Deshpande K; Arfuso F; Newsholme P; Dharmarajan A
    Mol Cancer; 2016 Nov; 15(1):69. PubMed ID: 27825361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondria Targeting as an Effective Strategy for Cancer Therapy.
    Ghosh P; Vidal C; Dey S; Zhang L
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pan-cancer analysis of tumor metabolic landscape associated with genomic alterations.
    Choi H; Na KJ
    Mol Cancer; 2018 Oct; 17(1):150. PubMed ID: 30333042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.